Published in Mol Ther Nucleic Acids on February 07, 2012
Extracellular vesicles: biology and emerging therapeutic opportunities. Nat Rev Drug Discov (2013) 4.35
Biological properties of extracellular vesicles and their physiological functions. J Extracell Vesicles (2015) 3.02
Sorting it out: regulation of exosome loading. Semin Cancer Biol (2014) 1.54
Role of exosomes/microvesicles in the nervous system and use in emerging therapies. Front Physiol (2012) 1.49
Exosomes: mediators of neurodegeneration, neuroprotection and therapeutics. Mol Neurobiol (2013) 1.32
Therapeutic applications of extracellular vesicles: clinical promise and open questions. Annu Rev Pharmacol Toxicol (2014) 1.29
Differential fates of biomolecules delivered to target cells via extracellular vesicles. Proc Natl Acad Sci U S A (2015) 1.27
FedExosomes: Engineering Therapeutic Biological Nanoparticles that Truly Deliver. Pharmaceuticals (Basel) (2013) 1.24
Oncogenic extracellular vesicles in brain tumor progression. Front Physiol (2012) 1.15
Genetically engineered microvesicles carrying suicide mRNA/protein inhibit schwannoma tumor growth. Mol Ther (2012) 1.10
The biology and function of exosomes in cancer. J Clin Invest (2016) 1.04
Extracellular Vesicles: Satellites of Information Transfer in Cancer and Stem Cell Biology. Dev Cell (2016) 0.99
Gene therapy for the nervous system: challenges and new strategies. Neurotherapeutics (2014) 0.98
The role of extracellular vesicles in the progression of neurodegenerative disease and cancer. Trends Mol Med (2014) 0.97
Extracellular vesicle isolation and characterization: toward clinical application. J Clin Invest (2016) 0.95
Biogenesis, delivery, and function of extracellular RNA. J Extracell Vesicles (2015) 0.92
KRAS-dependent sorting of miRNA to exosomes. Elife (2015) 0.91
Extracellular RNA mediates and marks cancer progression. Semin Cancer Biol (2014) 0.90
Signaling by exosomal microRNAs in cancer. J Exp Clin Cancer Res (2015) 0.90
Extracellular Vesicles: Composition, Biological Relevance, and Methods of Study. Bioscience (2015) 0.88
Extracellular vesicles and their synthetic analogues in aging and age-associated brain diseases. Biogerontology (2014) 0.87
Focus on Extracellular Vesicles: Physiological Role and Signalling Properties of Extracellular Membrane Vesicles. Int J Mol Sci (2016) 0.84
Use of genetically modified mesenchymal stem cells to treat neurodegenerative diseases. Int J Mol Sci (2014) 0.84
Extracellular Vesicles in Renal Pathophysiology. Front Mol Biosci (2017) 0.82
Enrichment of selective miRNAs in exosomes and delivery of exosomal miRNAs in vitro and in vivo. Am J Physiol Lung Cell Mol Physiol (2016) 0.80
Circulating RNA molecules as biomarkers in liver disease. Int J Mol Sci (2014) 0.80
Sorting signal targeting mRNA into hepatic extracellular vesicles. RNA Biol (2014) 0.80
Prostasomes as a source of diagnostic biomarkers for prostate cancer. J Clin Invest (2016) 0.79
Helicobacter pylori-induced posttranscriptional regulation of H-K-ATPase α-subunit gene expression by miRNA. Am J Physiol Gastrointest Liver Physiol (2014) 0.78
Podoplanin is a component of extracellular vesicles that reprograms cell-derived exosomal proteins and modulates lymphatic vessel formation. Oncotarget (2016) 0.77
Extracellular vesicles, tissue factor, cancer and thrombosis - discussion themes of the ISEV 2014 Educational Day. J Extracell Vesicles (2015) 0.77
A platform for actively loading cargo RNA to elucidate limiting steps in EV-mediated delivery. J Extracell Vesicles (2016) 0.77
Molecular Analysis of Neutrophil Differentiation from Human Induced Pluripotent Stem Cells Delineates the Kinetics of Key Regulators of Hematopoiesis. Stem Cells (2016) 0.77
Functional Delivery of Lipid-Conjugated siRNA by Extracellular Vesicles. Mol Ther (2017) 0.77
Functions of Cancer-Derived Extracellular Vesicles in Immunosuppression. Arch Immunol Ther Exp (Warsz) (2017) 0.76
Re-Engineering Extracellular Vesicles as Smart Nanoscale Therapeutics. ACS Nano (2017) 0.76
Extracellular Vesicles in Brain Tumor Progression. Cell Mol Neurobiol (2016) 0.76
Movement of regulatory RNA between animal cells. Genesis (2015) 0.76
Minireview: Emerging Roles for Extracellular Vesicles in Diabetes and Related Metabolic Disorders. Mol Endocrinol (2015) 0.76
High-throughput sequencing of two populations of extracellular vesicles provides an mRNA signature that can be detected in the circulation of breast cancer patients. RNA Biol (2016) 0.75
Extracellular vesicles for nucleic acid delivery: progress and prospects for safe RNA-based gene therapy. Gene Ther (2017) 0.75
Comprehensive proteome profiling of glioblastoma-derived extracellular vesicles identifies markers for more aggressive disease. J Neurooncol (2016) 0.75
Small Luggage for a Long Journey: Transfer of Vesicle-Enclosed Small RNA in Interspecies Communication. Front Microbiol (2017) 0.75
Tumor Microenvironment Modulation via Gold Nanoparticles Targeting Malicious Exosomes: Implications for Cancer Diagnostics and Therapy. Int J Mol Sci (2017) 0.75
Extracellular vesicle-mediated suicide mRNA/protein delivery inhibits glioblastoma tumor growth in vivo. Cancer Gene Ther (2016) 0.75
Exosomes of invasive urothelial carcinoma cells are characterized by a specific miRNA expression signature. Oncotarget (2017) 0.75
Extracellular vesicles as emerging targets in cancer: Recent development from bench to bedside. Biochim Biophys Acta (2017) 0.75
Extracellular vesicles in renal disease. Nat Rev Nephrol (2017) 0.75
MicroRNAs: genomics, biogenesis, mechanism, and function. Cell (2004) 198.59
Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol (2007) 37.10
Origins and Mechanisms of miRNAs and siRNAs. Cell (2009) 20.77
Biogenesis of small RNAs in animals. Nat Rev Mol Cell Biol (2009) 19.99
Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat Cell Biol (2008) 19.86
MicroRNA-dependent localization of targeted mRNAs to mammalian P-bodies. Nat Cell Biol (2005) 12.12
Regulation of mRNA translation and stability by microRNAs. Annu Rev Biochem (2010) 12.06
Antisense inhibition of human miRNAs and indications for an involvement of miRNA in cell growth and apoptosis. Nucleic Acids Res (2005) 9.80
Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes. Nat Biotechnol (2011) 9.68
Shedding microvesicles: artefacts no more. Trends Cell Biol (2009) 8.84
The highways and byways of mRNA decay. Nat Rev Mol Cell Biol (2007) 8.42
Intercellular transfer of the oncogenic receptor EGFRvIII by microvesicles derived from tumour cells. Nat Cell Biol (2008) 7.30
Membrane-derived microvesicles: important and underappreciated mediators of cell-to-cell communication. Leukemia (2006) 6.45
Sequences responsible for intracellular localization of beta-actin messenger RNA also affect cell phenotype. J Cell Biol (1994) 6.33
Embryonic stem cell-derived microvesicles reprogram hematopoietic progenitors: evidence for horizontal transfer of mRNA and protein delivery. Leukemia (2006) 6.31
Multivesicular bodies associate with components of miRNA effector complexes and modulate miRNA activity. Nat Cell Biol (2009) 6.03
mRNA localization: gene expression in the spatial dimension. Cell (2009) 5.50
Characterization of a beta-actin mRNA zipcode-binding protein. Mol Cell Biol (1997) 5.21
Tumour microvesicles contain retrotransposon elements and amplified oncogene sequences. Nat Commun (2011) 4.07
Isoform-specific 3'-untranslated sequences sort alpha-cardiac and beta-cytoplasmic actin messenger RNAs to different cytoplasmic compartments. J Cell Biol (1993) 3.49
mRNA localization: message on the move. Nat Rev Mol Cell Biol (2001) 3.04
Microvesicles: messengers and mediators of tumor progression. Cell Cycle (2009) 2.66
Treatment of brain inflammatory diseases by delivering exosome encapsulated anti-inflammatory drugs from the nasal region to the brain. Mol Ther (2011) 2.61
Exfoliation of membrane ecto-enzymes in the form of micro-vesicles. Biochim Biophys Acta (1981) 2.51
Exosomes as intercellular signalosomes and pharmacological effectors. Biochem Pharmacol (2011) 2.34
To localize or not to localize: mRNA fate is in 3'UTR ends. Trends Cell Biol (2009) 2.26
Differential expression of pleiotrophin and midkine in advanced neuroblastomas. Cancer Res (1995) 1.72
Microparticles in cancer. Semin Thromb Hemost (2010) 1.57
Protein targeting to exosomes/microvesicles by plasma membrane anchors. J Biol Chem (2011) 1.56
A new family of heparin-binding growth/differentiation factors: increased midkine expression in Wilms' tumor and other human carcinomas. Cancer Res (1993) 1.55
miRNA-7 attenuation in Schwannoma tumors stimulates growth by upregulating three oncogenic signaling pathways. Cancer Res (2010) 1.54
Increased midkine gene expression in human gastrointestinal cancers. Jpn J Cancer Res (1995) 1.39
The angiogenic factor midkine is expressed in bladder cancer, and overexpression correlates with a poor outcome in patients with invasive cancers. Cancer Res (1996) 1.31
An ex(o)citing machinery for invasive tumor growth. Cancer Res (2010) 1.31
Brain tumor microvesicles: insights into intercellular communication in the nervous system. Cell Mol Neurobiol (2011) 1.22
Transmitting the message: intracellular mRNA localization. Curr Opin Cell Biol (2010) 1.18
Increased expression of midkine during the progression of human astrocytomas. Neurosci Lett (1997) 1.18
Conditioned media from cell lines: a complementary model to clinical specimens for the discovery of disease-specific biomarkers. Proteomics (2011) 1.14
Reciprocal expression of pleiotrophin and midkine in normal versus malignant lung tissues. Am J Respir Cell Mol Biol (1993) 1.13
Immunohistochemical analysis of midkine expression in human prostate carcinoma. Oncology (1999) 1.10
miRNA signature of schwannomas: possible role(s) of "tumor suppressor" miRNAs in benign tumors. Oncotarget (2011) 1.01
Herpes simplex virus 1 amplicon vector-mediated siRNA targeting epidermal growth factor receptor inhibits growth of human glioma cells in vivo. Mol Ther (2005) 1.01
Identification of an inhibitory budding signal that blocks the release of HIV particles and exosome/microvesicle proteins. Mol Biol Cell (2011) 1.00
The midkine family in cancer, inflammation and neural development. Nagoya J Med Sci (2005) 0.89
Galanin and galanin receptors in human cancers. Neuropeptides (2005) 0.85
A second generation human haplotype map of over 3.1 million SNPs. Nature (2007) 85.39
Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat Cell Biol (2008) 19.86
Genome-wide detection and characterization of positive selection in human populations. Nature (2007) 17.27
High density DNA methylation array with single CpG site resolution. Genomics (2011) 10.35
High-throughput DNA methylation profiling using universal bead arrays. Genome Res (2006) 8.05
Characterization of the single-cell transcriptional landscape by highly multiplex RNA-seq. Genome Res (2011) 6.90
Codon-optimized Gaussia luciferase cDNA for mammalian gene expression in culture and in vivo. Mol Ther (2005) 6.04
Extracellular vesicles: biology and emerging therapeutic opportunities. Nat Rev Drug Discov (2013) 4.35
Protein typing of circulating microvesicles allows real-time monitoring of glioblastoma therapy. Nat Med (2012) 4.11
Tumour microvesicles contain retrotransposon elements and amplified oncogene sequences. Nat Commun (2011) 4.07
Profiling alternative splicing on fiber-optic arrays. Nat Biotechnol (2002) 3.94
Differential allelic expression in the human genome: a robust approach to identify genetic and epigenetic cis-acting mechanisms regulating gene expression. PLoS Genet (2008) 3.92
High-throughput SNP genotyping on universal bead arrays. Mutat Res (2005) 3.78
DNA methylation signatures within the human brain. Am J Hum Genet (2007) 3.50
Decoding randomly ordered DNA arrays. Genome Res (2004) 3.49
A secreted luciferase for ex vivo monitoring of in vivo processes. Nat Methods (2008) 3.31
Epigenomic analysis detects widespread gene-body DNA hypomethylation in chronic lymphocytic leukemia. Nat Genet (2012) 3.08
Functional analysis of human microtubule-based motor proteins, the kinesins and dyneins, in mitosis/cytokinesis using RNA interference. Mol Biol Cell (2005) 3.04
Quantitative gene expression profiling in formalin-fixed, paraffin-embedded tissues using universal bead arrays. Am J Pathol (2004) 3.04
Human embryonic stem cells have a unique epigenetic signature. Genome Res (2006) 2.89
A highly informative SNP linkage panel for human genetic studies. Nat Methods (2004) 2.74
microRNA-29a induces aberrant self-renewal capacity in hematopoietic progenitors, biased myeloid development, and acute myeloid leukemia. J Exp Med (2010) 2.68
Combining clinical, pathology, and gene expression data to predict recurrence of hepatocellular carcinoma. Gastroenterology (2011) 2.66
A highly sensitive assay for monitoring the secretory pathway and ER stress. PLoS One (2007) 2.63
miR-296 regulates growth factor receptor overexpression in angiogenic endothelial cells. Cancer Cell (2008) 2.57
Comprehensive microRNA profiling reveals a unique human embryonic stem cell signature dominated by a single seed sequence. Stem Cells (2008) 2.52
Integrative molecular analysis of intrahepatic cholangiocarcinoma reveals 2 classes that have different outcomes. Gastroenterology (2013) 2.42
Gene-expression signature of vascular invasion in hepatocellular carcinoma. J Hepatol (2011) 2.39
Degradation of fibrillar collagen in a human melanoma xenograft improves the efficacy of an oncolytic herpes simplex virus vector. Cancer Res (2006) 2.35
Whole-genome gene expression profiling of formalin-fixed, paraffin-embedded tissue samples. PLoS One (2009) 2.21
Highly multiplexed and strand-specific single-cell RNA 5' end sequencing. Nat Protoc (2012) 2.21
Sensitive ChIP-DSL technology reveals an extensive estrogen receptor alpha-binding program on human gene promoters. Proc Natl Acad Sci U S A (2007) 2.17
GoldenGate assay for DNA methylation profiling. Methods Mol Biol (2009) 2.15
Succinate dehydrogenase mutation underlies global epigenomic divergence in gastrointestinal stromal tumor. Cancer Discov (2013) 2.11
Two-dimensional transcriptome profiling: identification of messenger RNA isoform signatures in prostate cancer from archived paraffin-embedded cancer specimens. Cancer Res (2006) 2.11
Downregulated microRNA-200a in meningiomas promotes tumor growth by reducing E-cadherin and activating the Wnt/beta-catenin signaling pathway. Mol Cell Biol (2009) 2.06
TorsinA in the nuclear envelope. Proc Natl Acad Sci U S A (2004) 2.06
New insights into the biology and origin of mature aggressive B-cell lymphomas by combined epigenomic, genomic, and transcriptional profiling. Blood (2008) 1.97
Viral vectors for gene delivery to the nervous system. Nat Rev Neurosci (2003) 1.86
Analysis of gene expression in stage I serous tumors identifies critical pathways altered in ovarian cancer. Gynecol Oncol (2009) 1.82
TorsinA binds the KASH domain of nesprins and participates in linkage between nuclear envelope and cytoskeleton. J Cell Sci (2008) 1.80
Expression signatures that correlated with Gleason score and relapse in prostate cancer. Genomics (2007) 1.78
TorsinA and heat shock proteins act as molecular chaperones: suppression of alpha-synuclein aggregation. J Neurochem (2002) 1.77
Mutant torsinA interferes with protein processing through the secretory pathway in DYT1 dystonia cells. Proc Natl Acad Sci U S A (2007) 1.73
Identification of a novel gene (HSN2) causing hereditary sensory and autonomic neuropathy type II through the Study of Canadian Genetic Isolates. Am J Hum Genet (2004) 1.70
Genome-wide mapping of allele-specific protein-DNA interactions in human cells. Nat Methods (2008) 1.69
Intravascular delivery of neural stem cell lines to target intracranial and extracranial tumors of neural and non-neural origin. Hum Gene Ther (2003) 1.65
Microfluidic isolation and transcriptome analysis of serum microvesicles. Lab Chip (2009) 1.61
A peculiar constellation of tau pathology defines a subset of dementia in the elderly. Acta Neuropathol (2011) 1.60
Large-scale profiling of archival lymph nodes reveals pervasive remodeling of the follicular lymphoma methylome. Cancer Res (2009) 1.58
Unraveling epigenetic regulation in embryonic stem cells. Cell Stem Cell (2008) 1.57
miRNA-7 attenuation in Schwannoma tumors stimulates growth by upregulating three oncogenic signaling pathways. Cancer Res (2010) 1.54
Highly sensitive and specific microRNA expression profiling using BeadArray technology. Nucleic Acids Res (2008) 1.54
A pan-European study of the C9orf72 repeat associated with FTLD: geographic prevalence, genomic instability, and intermediate repeats. Hum Mutat (2013) 1.53
Metabolic biotinylation of cell surface receptors for in vivo imaging. Nat Methods (2006) 1.50
Microvesicle-associated AAV vector as a novel gene delivery system. Mol Ther (2012) 1.49
Glioma therapy and real-time imaging of neural precursor cell migration and tumor regression. Ann Neurol (2005) 1.48
A comprehensive microarray-based DNA methylation study of 367 hematological neoplasms. PLoS One (2009) 1.48
Whole-genome haplotyping by dilution, amplification, and sequencing. Proc Natl Acad Sci U S A (2013) 1.44
Dystonia-causing mutant torsinA inhibits cell adhesion and neurite extension through interference with cytoskeletal dynamics. Neurobiol Dis (2005) 1.44
RNA expression patterns in serum microvesicles from patients with glioblastoma multiforme and controls. BMC Cancer (2012) 1.43
APOBEC3B upregulation and genomic mutation patterns in serous ovarian carcinoma. Cancer Res (2013) 1.43
TorsinA in PC12 cells: localization in the endoplasmic reticulum and response to stress. J Neurosci Res (2003) 1.42
Impaired motor learning in mice expressing torsinA with the DYT1 dystonia mutation. J Neurosci (2005) 1.41
Dopamine release is impaired in a mouse model of DYT1 dystonia. J Neurochem (2007) 1.41
BEAMing and Droplet Digital PCR Analysis of Mutant IDH1 mRNA in Glioma Patient Serum and Cerebrospinal Fluid Extracellular Vesicles. Mol Ther Nucleic Acids (2013) 1.40
TorsinA protein and neuropathology in early onset generalized dystonia with GAG deletion. Neurobiol Dis (2003) 1.39
Profiling alternatively spliced mRNA isoforms for prostate cancer classification. BMC Bioinformatics (2006) 1.39
Brain protein preservation largely depends on the postmortem storage temperature: implications for study of proteins in human neurologic diseases and management of brain banks: a BrainNet Europe Study. J Neuropathol Exp Neurol (2007) 1.38
Age-dependent brain gene expression and copy number anomalies in autism suggest distinct pathological processes at young versus mature ages. PLoS Genet (2012) 1.37
Genome-wide DNA methylation profiling. Wiley Interdiscip Rev Syst Biol Med (2010) 1.37
Effects of formalin fixation, paraffin embedding, and time of storage on DNA preservation in brain tissue: a BrainNet Europe study. Brain Pathol (2007) 1.36
The transcriptional architecture of early human hematopoiesis identifies multilevel control of lymphoid commitment. Nat Immunol (2013) 1.35
Effects of genetic variations in the dystonia protein torsinA: identification of polymorphism at residue 216 as protein modifier. Hum Mol Genet (2006) 1.35
Chemical enhancement of torsinA function in cell and animal models of torsion dystonia. Dis Model Mech (2010) 1.33
Level of Id-1 protein expression correlates with poor differentiation, enhanced malignant potential, and more aggressive clinical behavior of epithelial ovarian tumors. Clin Cancer Res (2003) 1.32
Angiogenic mRNA and microRNA gene expression signature predicts a novel subtype of serous ovarian cancer. PLoS One (2012) 1.31
Epigenetic specificity of loss of imprinting of the IGF2 gene in Wilms tumors. J Natl Cancer Inst (2007) 1.29
MiR-21 in the extracellular vesicles (EVs) of cerebrospinal fluid (CSF): a platform for glioblastoma biomarker development. PLoS One (2013) 1.25
FGF-2 regulates neurogenesis and degeneration in the dentate gyrus after traumatic brain injury in mice. J Clin Invest (2003) 1.24
Spatial analysis of arabidopsis thaliana gene expression in response to Turnip mosaic virus infection. Mol Plant Microbe Interact (2007) 1.23
Brain tumor microvesicles: insights into intercellular communication in the nervous system. Cell Mol Neurobiol (2011) 1.22
Mutant sodium channel for tumor therapy. Mol Ther (2009) 1.22
Extracellular vesicles and their convergence with viral pathways. Adv Virol (2012) 1.18
TorsinA participates in endoplasmic reticulum-associated degradation. Nat Commun (2011) 1.18
Translating the genomics revolution: the need for an international gene therapy consortium for monogenic diseases. Mol Ther (2013) 1.16
The early onset dystonia protein torsinA interacts with kinesin light chain 1. J Biol Chem (2004) 1.16
siRNA knock-down of mutant torsinA restores processing through secretory pathway in DYT1 dystonia cells. Hum Mol Genet (2008) 1.15
Salicylic acid-dependent expression of host genes in compatible Arabidopsis-virus interactions. Plant Physiol (2005) 1.13
The early-onset torsion dystonia-associated protein, torsinA, is a homeostatic regulator of endoplasmic reticulum stress response. Hum Mol Genet (2010) 1.13
In vivo imaging of S-TRAIL-mediated tumor regression and apoptosis. Mol Ther (2005) 1.12
Expression of an active tobacco mitogen-activated protein kinase kinase kinase enhances freezing tolerance in transgenic maize. Proc Natl Acad Sci U S A (2004) 1.12
Developmental patterns of torsinA and torsinB expression. Brain Res (2006) 1.12
A novel method for imaging apoptosis using a caspase-1 near-infrared fluorescent probe. Neoplasia (2004) 1.11
Low-level expression of miR-375 correlates with poor outcome and metastasis while altering the invasive properties of head and neck squamous cell carcinomas. Am J Pathol (2012) 1.11